MedPath

Lumretuzumab

Generic Name
Lumretuzumab
Drug Type
Biotech
CAS Number
1448327-63-6
Unique Ingredient Identifier
Y6M3205516
Background

Lumretuzumab has been used in trials studying the treatment of Neoplasms, Breast Cancer, Squamous Non-Small Cell Lung Cancer, and Non-Squamous Non-Small Cell Lung Cancer.

© Copyright 2025. All Rights Reserved by MedPath